Trials / Unknown
UnknownNCT04400916
Topical Tranexamic Acid After Intravitreal Injections
Topical Use of Tranexamic Acid for Prevention of Subconjunctival Hemorrhage After Intravitreal Injections
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Rambam Health Care Campus · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
We aim to investigate whether topical administration of Tranexamic acid can reduce the occurence of subconjunctival hemorrahge after routine intravitreal injections for retinal conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tranexamic acid | A single drop administered topically |
| OTHER | Balanced Salt Solution | A single drop administered topically |
Timeline
- Start date
- 2020-09-01
- Primary completion
- 2021-09-01
- Completion
- 2021-12-01
- First posted
- 2020-05-26
- Last updated
- 2020-05-26
Source: ClinicalTrials.gov record NCT04400916. Inclusion in this directory is not an endorsement.